Hydrogen-rich water alleviates inflammation and fatigue in COVID-19: A pilot study
by Nikola Todorovic, Sergej M. Ostojic, Valdemar Stajer, Aleksandra Milovancev, Jovana Avakumovic, Partik Drid
Abstract:
This study investigates the potential therapeutic benefits of hydrogen-rich water (HRW) in treating COVID-19 symptoms through a double-blind randomized placebo-controlled trial involving 24 patients with mild to moderate COVID-19. Participants consumed 1.5 liters of HRW daily for 14 days, where HRW was produced via a reaction of magnesium with water, yielding hydrogen gas and magnesium hydroxide. The placebo was matched for magnesium content and appearance. Primary outcomes assessed included patient-reported symptoms and oxygen saturation, while secondary outcomes focused on biomarkers of inflammation and coagulation. Results showed no significant improvement in most reported symptoms or oxygen saturation; however, HRW consumption led to a significant reduction in fatigue and modified prothrombin time and interleukin-6 levels, suggesting potential anti-inflammatory effects. The findings indicate that HRW may have specific benefits in alleviating disease-related fatigue and impacting blood coagulation and inflammatory markers, particularly in female patients. Further research is needed to explore the full potential and mechanisms of HRW in COVID-19 treatment, considering the pilot nature of this study and its limitations in sample size and demographic representation.
Read more:
https://doi.org/10.1177/1721727X221094197
Related Articles:
Background: Activated inflammatory cells produce reactive oxygen species (ROS) to eliminate pathogens. Under normal conditions, the pathogens are taken care of, and tissues are repaired. However, in periodontal disease, persistent inflammation causes increased ROS release and impaired healing. Therefore, removal…
Objective: To investigate the effect of hydrogen gas on NOD-like receptor protein 3 (NLRP3) inflammasomes in the cerebral cortex of rats with traumatic brain injury (TBI). Methods: 120 adult male Sprague-Dawley (SD) rates were randomly divided into 5 groups (n…
Background: Hydrogen/oxygen therapy contribute to ameliorate dyspnea and disease progression in patients with respiratory diseases. Therefore, we hypothesized that hydrogen/oxygen therapy for ordinary coronavirus disease 2019 (COVID-19) patients might reduce the length of hospitalization and increase hospital discharge rates. Methods:…
Introduction: With the global population aging, there is an increased prevalence of sepsis among the elderly, a demographic particularly susceptible to inflammation. This study aimed to evaluate the therapeutic potential of hydrogen gas, known for its anti-inflammatory and antioxidant properties,…
Clinical studies had found that hydrogen/oxygen mixed inhalation was beneficial to ameliorate the respiratory symptoms in the adjuvant treatment of patients with COVID-19. We aimed to explore the efficacy of hydrogen/oxygen therapy in favoring the recovery of Omicron SARS-CoV-2 variant…
Traumatic brain injury (TBI) has been recognized as a serious public health issue and a key contributor to disability and death, with a huge economic burden worldwide. Hydrogen, which is a slight and specific cytotoxic oxygen radical scavenger, has been…
0 Comments